Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32,260 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic Impact of Inflammation-Based Factors in Patients with Esophageal Squamous Cell Carcinoma Achieving Pathological Complete Response After Neoadjuvant Chemoradiotherapy Followed by Surgery.
Kim JY, Yun JK, Kim YH, Park SI, Lee JH, Jung HY, Lee GH, Song HJ, Kim DH, Choi KD, Ahn JY, Kim SB, Cho KJ, Ryu JS, Kim JH, Kang J, Park SR, Kim HR. Kim JY, et al. Among authors: kim yh, kim sb, kim dh, kim hr, kim jh. Ann Surg Oncol. 2024 Oct;31(10):6662-6672. doi: 10.1245/s10434-024-15678-y. Epub 2024 Jul 2. Ann Surg Oncol. 2024. PMID: 38954089
FDG-PET in the prediction of pathologic response after neoadjuvant chemoradiotherapy in locally advanced, resectable esophageal cancer.
Song SY, Kim JH, Ryu JS, Lee GH, Kim SB, Park SI, Song HY, Cho KJ, Ahn SD, Lee SW, Shin SS, Choi EK. Song SY, et al. Among authors: kim sb, kim jh. Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1053-9. doi: 10.1016/j.ijrobp.2005.03.033. Epub 2005 Jun 20. Int J Radiat Oncol Biol Phys. 2005. PMID: 15964705 Clinical Trial.
Value of complete metabolic response by (18)F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy.
Kim MK, Ryu JS, Kim SB, Ahn JH, Kim SY, Park SI, Kim YH, Song HY, Shin JH, Jung HY, Lee GH, Choi KD, Cho KJ, Kim JH. Kim MK, et al. Among authors: kim sb, kim yh, kim sy, kim jh. Eur J Cancer. 2007 Jun;43(9):1385-91. doi: 10.1016/j.ejca.2007.04.001. Epub 2007 May 23. Eur J Cancer. 2007. PMID: 17512192 Clinical Trial.
32,260 results
You have reached the last available page of results. Please see the User Guide for more information.